Ovarian germ cell malignancies: the Yale University experience

UK real-world evidence on pembrolizumab and neoadjuvant chemotherapy for early-stage triple-negative breast cancer.

ESMO real world data and digital oncology·2026

Multifaceted modulation of human opioid receptors by kratom alkaloids: binding affinity, functional selectivity, and allosteric activity.

Frontiers in pharmacology·2026

A Geospatial Analysis of Social and Structural Determinants of Health and High HIV Prevalence in Alabama, USA.

Journal of community health·2023

The incidence of malignancy in the residual rectum of IBD patients after colectomy: a systematic review and meta-analysis.

Techniques in coloproctology·2023

Trends and prospects of geothermal energy as an alternative source of power: A comprehensive review.

Heliyon·2022

Medication-assisted treatment and self-help group participation among military veterans with opioid or alcohol use disorder.

BMJ military health·2021

Early-phase vs. late-phase clinical trials in gynecologic oncology: Trends in trial completion, reporting, and enrollment of racial and ethnic minority groups.

Gynecologic oncology·2026

Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination-deficient stage III/IV ovarian cancer: Findings from cohort C of the OPAL phase 2 trial.

Gynecologic oncology·2026

Evaluating a patient ambassador program to improve clinical trial knowledge and intent to discuss gynecologic oncology trials.

Gynecologic oncology·2026

Incidence, prevalence, mortality and survival trends in women with endometrial-, ovarian- and cervical cancer in the Nordic countries (1980-2023) with focus on younger women (0-49 years old).

Gynecologic oncology·2026

Predicting residual disease and extent of surgery after neoadjuvant chemotherapy for ovarian cancer: Does the MSKCC model from the primary setting apply?

Gynecologic oncology·2026

Feedback activation of MAPK-ERK1/2 signaling causes resistance to trastuzumab-deruxtecan in endometrial cancers.

Gynecologic oncology·2026

Anterior Mediastinal Germ Cell Tumor Presenting With Superior Vena Cava Obstruction and Malignant Pericardial Effusion.

Cureus·2026

Obesity at antiretroviral therapy initiation and long-term risk of cardiovascular disease, cancer, or death in people with HIV in Italy: a prospective cohort study.

EClinicalMedicine·2026

Spontaneous Tumor Lysis Syndrome Revealing Advanced Ovarian Carcinoma: From Oncologic Emergency to Complete Pathologic Response.

Cureus·2026

The solitary skull mass: An atypical presentation of anaplastic large cell lymphoma.

Radiology case reports·2026

Disseminated intravascular coagulation in chimeric antigen receptor T-cell therapy: a 6-year nationwide analysis of clinical outcomes and health care resource utilization in patients with hematologic malignancies.

Research and practice in thrombosis and haemostasis·2026

Predominantly cystic glioblastoma mimicking benign cystic lesions: A radiological diagnostic challenge.

Radiology case reports·2026

Related Experiment Videos

Ovarian germ cell malignancies: the Yale University experience

Related Concept Videos

UK real-world evidence on pembrolizumab and neoadjuvant chemotherapy for early-stage triple-negative breast cancer.

Multifaceted modulation of human opioid receptors by kratom alkaloids: binding affinity, functional selectivity, and allosteric activity.

A Geospatial Analysis of Social and Structural Determinants of Health and High HIV Prevalence in Alabama, USA.

The incidence of malignancy in the residual rectum of IBD patients after colectomy: a systematic review and meta-analysis.

Trends and prospects of geothermal energy as an alternative source of power: A comprehensive review.

Medication-assisted treatment and self-help group participation among military veterans with opioid or alcohol use disorder.

Early-phase vs. late-phase clinical trials in gynecologic oncology: Trends in trial completion, reporting, and enrollment of racial and ethnic minority groups.

Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination-deficient stage III/IV ovarian cancer: Findings from cohort C of the OPAL phase 2 trial.

Evaluating a patient ambassador program to improve clinical trial knowledge and intent to discuss gynecologic oncology trials.

Incidence, prevalence, mortality and survival trends in women with endometrial-, ovarian- and cervical cancer in the Nordic countries (1980-2023) with focus on younger women (0-49 years old).

Predicting residual disease and extent of surgery after neoadjuvant chemotherapy for ovarian cancer: Does the MSKCC model from the primary setting apply?

Feedback activation of MAPK-ERK1/2 signaling causes resistance to trastuzumab-deruxtecan in endometrial cancers.

Anterior Mediastinal Germ Cell Tumor Presenting With Superior Vena Cava Obstruction and Malignant Pericardial Effusion.

Obesity at antiretroviral therapy initiation and long-term risk of cardiovascular disease, cancer, or death in people with HIV in Italy: a prospective cohort study.

Spontaneous Tumor Lysis Syndrome Revealing Advanced Ovarian Carcinoma: From Oncologic Emergency to Complete Pathologic Response.

The solitary skull mass: An atypical presentation of anaplastic large cell lymphoma.

Disseminated intravascular coagulation in chimeric antigen receptor T-cell therapy: a 6-year nationwide analysis of clinical outcomes and health care resource utilization in patients with hematologic malignancies.

Predominantly cystic glioblastoma mimicking benign cystic lesions: A radiological diagnostic challenge.

Related Experiment Videos

Ovarian germ cell malignancies: the Yale University experience

Related Concept Videos

Related Articles